Amrit Srečko Šorli*, Tomaž Makovec, Živan Krevel and Rado Gorjup
Background: The main impetus behind the worldwide COVID-19 vaccination campaign in 2021 was to reduce the mortality attributed to SARS-CoV-2 infection in the preceding year. Nevertheless, rigorous analyses of the mortality benefits conferred by this massive vaccination effort have been lacking.
Methods: Statistics offers us an essential methodological approach for measuring the impacts of COVID-19 vaccination on public health. The mathematical relation between vaccinated alive groups can be repeated between vaccinated dead groups with relatively high statistical reliability because of the large population numbers involved. This method also confers greater statistical usefulness because it eliminates the Simpson effect.
Results: Calculations were performed for each of the following 5-4 week intervals: weeks 35-38 (2021), weeks 39-42 (2021), weeks 43-46 (2021), weeks 47-50 (2021), and weeks 50(2021)-1(2022). The results obtained confirm that the mortality of the vaccinated coronavirus infected groups was 14.5% higher on average than the mortality of non-vaccinated coronavirus infected groups.
Conclusion: Vaccinated infected groups appear to have higher average mortality than their non-vaccinated infected counterparts. The findings suggest the legitimacy of extending the statistics between vaccinated livings and vaccinated dead individuals for different age groups. Calculating the impact of COVID-19 vaccination on the mortality rate is a necessary step towards satisfying the first principle of medicine: “Primum non nocere”, “First do no harm”.
Published Date: 2023-01-28; Received Date: 2023-01-31
